Sontoria D King, Swathi Veliginti, Martijn C G J Brouwers, Zhewen Ren, Wei Zheng, Veronica Wendy Setiawan, Lynne R Wilkens, Xiao-Ou Shu, Alan A Arslan, Laura E Beane Freeman, Paige M Bracci, Federico Canzian, Mengmeng Du, Steven J Gallinger, Graham G Giles, Phyllis J Goodman, Christopher A Haiman, Manolis Kogevinas, Charles Kooperberg, Loic Le Marchand, Rachel E Neale, Kala Visvanathan, Emily White, Demetrius Albanes, Gabriella Andreotti, Ana Babic, Sonja I Berndt, Lauren K Brais, Paul Brennan, Julie E Buring, Kari G Rabe, William R Bamlet, Stephen J Chanock, Charles S Fuchs, J Michael Gaziano, Edward L Giovannucci, Thilo Hackert, Manal M Hassan, Verena Katzke, Robert C Kurtz, I-Min Lee, Nuria Malats, Neil Murphy, Ann L Oberg, Irene Orlow, Miquel Porta, Francisco X Real, Nathaniel Rothman, Howard D Sesso, Debra T Silverman, Ian M Thompson, Jean Wactawski-Wende, Xiaoliang Wang, Nicolas Wentzensen, Herbert Yu, Anne Zeleniuch-Jacquotte, Kai Yu, Brian M Wolpin, Eric J Duell, Donghui Li, Rayjean J Hung, Sandra Perdomo, Marjorie L McCullough, Neal D Freedman, Alpa V Patel, Ulrike Peters, Elio Riboli, Malin Sund, Anne Tjønneland, Jun Zhong, Stephen K Van Den Eeden, Peter Kraft, Harvey A Risch, Laufey T Amundadottir, Alison P Klein, Rachael Z Stolzenberg-Solomon, Samuel O Antwi
BACKGROUND: There are conflicting data on whether nonalcoholic fatty liver disease (NAFLD) is associated with susceptibility to pancreatic cancer (PC). Using Mendelian randomization (MR), we investigated the relationship between genetic predisposition to NAFLD and risk for PC. METHODS: Data from genome-wide association studies within the Pancreatic Cancer Cohort Consortium (PanScan; cases n=5090, controls n=8733) and the Pancreatic Cancer Case Control Consortium (PanC4; cases n=4,163, controls n=3,792) were analyzed...
June 23, 2023: Cancer Epidemiology, Biomarkers & Prevention